Overview

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study

Status:
Unknown status
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
A multicentre, prospective randomized, active-controlled feasibility trial of volatile-based anaesthesia vs. propofol-based total intravenous anaesthesia to investigate the impact of anaesthesia on long-term (i.e. 5-years) patient cancer outcomes in patients undergoing elective major cancer surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Peter MacCallum Cancer Centre, Australia
Collaborators:
M.D. Anderson Cancer Center
Melbourne Health
The Alfred
Treatments:
Anesthetics
Desflurane
Isoflurane
Propofol
Sevoflurane